CBD

Benzinga recently reported about numerous former football players getting involved with cannabis and CBD companies. Playboy featured testimonies from eight former NFL players who support cannabis and cannabis-derived therapeutics. But it's not just football players getting behind the herb....

The discussion about cannabis and sports isn't new. The conversation gained more relevance than ever late last year after the World Anti-Doping Agency, in charge of drug testing among Olympic athletes and usually sets the criteria for anti-doping in most sports across the globe, removed CBD...

Medical journal The Lancet published an article Wednesday that could mold the future of cannabis-derived therapeutics. The piece in question featured results from GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) and Greenwich Biosciences’ Phase 3 study of Epidiolex — an oral cannabidiol...

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) traded up as much as 82.6 percent Thursday after reporting positive top-line results for its uncontrolled phase 2 study of ZYN002 in children with Fragile X syndrome. The synthetic cannabinoid transdermal gel “successfully met its primary endpoint...

The Southeast Cannabis Conference & Expo has just kicked off in Fort Lauderdale, Florida, and will go on until Sunday afternoon. This non-consumption event is aimed at educating, engaging and empowering “the cannabis industry of tomorrow,” Executive Operations Director Danielle...

Being a one-trick pony can always prove risky. This rationale seems to have dawned on GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH), a biopharmaceutical company specializing in prescription cannabinoid medicine. Risk Mitigation Through Diversification The company announced Tuesday positive top...

In a report issued Monday, Canaccord analysts Corey Davis and Lidia Liu initiated coverage on shares of Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) with a Buy rating. The experts set a $35.00 price target for the stock. The company is differentiated by its synthetic manufacturing and transdermal...

With medical and recreational marijuana quickly becoming a booming business in the U.S., farmers with newly issued licenses to grow hemp are finding it difficult to carve out their own place in the market. Hemp farmers in several states are beginning their second growing season this year, though...

(Note: This is the second of a two-part interview with Terra Tech Corp. CEO Derek Peterson. Click here for part one) Terra Tech Corp (OTC: TRTC), and its subsidiary, GrowOp Technology Ltd, is working on the development of a CBD supplement with the medical research firm Intergetics (OTC: NRTI...